| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/2009 | CA2196184C Sustained release preparation containing metal salt of a peptide |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/04/2009 | WO2009070786A2 Peptide and multivalent peptide conjugate for diagnosis and treatment of vascular plaques |
| 06/04/2009 | WO2009070698A1 Microsphere skin treatment |
| 06/04/2009 | WO2009070692A1 C5-substituted, proline-derived, macrocyclic hepatitis c serine protease inhibitors |
| 06/04/2009 | WO2009070689A1 Bicyclic, c5-substituted proline derivatives as inhibitors of the hepatitis c virus ns3 protease |
| 06/04/2009 | WO2009070652A1 Method of treating cancer |
| 06/04/2009 | WO2009070564A2 Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
| 06/04/2009 | WO2009070551A1 Use of somatostatin analogs in meningioma |
| 06/04/2009 | WO2009070298A1 Method of delaying the onset of clinically definite multiple sclerosis |
| 06/04/2009 | WO2009070211A1 Sustained release of apo a-i mimetic peptides and methods of producing them |
| 06/04/2009 | WO2009070210A2 Sustained release of apo a-i mimetic peptides and methods for delivery in situ |
| 06/04/2009 | WO2009070209A2 Sustained release of apo a-i mimetic peptides and methods of producing them |
| 06/04/2009 | WO2009070088A1 Antimicrobial polypeptide |
| 06/04/2009 | WO2009070080A1 New insulin for diabetics on persons with overweight |
| 06/04/2009 | WO2009069983A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 06/04/2009 | WO2009069917A1 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection |
| 06/04/2009 | WO2009069682A1 Therapeutic agent or preventive agent for hepatitis |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke |
| 06/04/2009 | WO2009069022A1 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues |
| 06/04/2009 | WO2009068926A1 Use of urokinase type plasminogen activator inhibitors for the treatment of corneal disorders |
| 06/04/2009 | WO2009068911A1 Compositions and methods for reducing macrovascular complications in diabetic patients |
| 06/04/2009 | WO2009068689A2 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
| 06/04/2009 | WO2009068602A2 Oral care compositions comprising casein, ovalbumin, whey or soy protein |
| 06/04/2009 | WO2009068600A1 Compositions for reducing dental erosion |
| 06/04/2009 | WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | WO2009067813A1 Apurinic/apyrimidinic endonuclease 1 (ape1) for use in the treatment of disorders associated with aberrant rna transcription, aberrant microrna transcription, viral rna transcription, and aberrant c-myc rna transcription |
| 06/04/2009 | WO2009067791A1 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 06/04/2009 | WO2009067790A1 STIMULATION OF HYPOXIA INDUCIBLE FACTOR -1 ALPHA (HIF-1α) FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE (CDAD), FOR INTESTINAL MOTILITY AND FOR DETECTING INFECTION |
| 06/04/2009 | WO2009067757A1 Methods of inducing pluripotency involving oct4 protein |
| 06/04/2009 | WO2009067756A1 Methods of inducing pluripotency involving sox2 protein |
| 06/04/2009 | WO2009052489A3 Novel inhibitors of mammalian tight junction opening |
| 06/04/2009 | WO2009050267A3 Il24 for inducing hyperproliferative or autoimmune cell death |
| 06/04/2009 | WO2009045309A3 Use of v2 receptor antagonists in combination with vasopressinergic agonists |
| 06/04/2009 | WO2009044059A3 Implantable preparations containing globin, method for the production thereof and uses |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009034452A3 Compound and device for treating bone and/or cartilage defects |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009029801A3 Selective cytopheresis devices and related methods thereof |
| 06/04/2009 | WO2009024346A3 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 06/04/2009 | WO2009013115A3 Vesicles comprising a transmembrane transport trigger system |
| 06/04/2009 | WO2008143880A3 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 06/04/2009 | WO2008137054A3 Composition for transmucosal delivery of polypeptides |
| 06/04/2009 | WO2007018585A3 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition |
| 06/04/2009 | WO2006081014A3 Cytochrome p450 enzyme complexes and methods of treatment using the same |
| 06/04/2009 | WO2006012586A3 Modulation of fiaf and the gastrointestinal microbiota |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144852 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 06/04/2009 | US20090144840 Beta-secretase enzyme compositions and methods |
| 06/04/2009 | US20090143763 Rotatable infusion set |
| 06/04/2009 | US20090143761 Agent delivery system and uses of same |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 06/04/2009 | US20090143314 Compositions and methods for combination antiviral therapy |
| 06/04/2009 | US20090143313 Treatment or Prevention of Hemorrhagic Viral Infections with Immunomodulator Compounds |
| 06/04/2009 | US20090143312 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/04/2009 | US20090143311 Compositions comprising tripeptides inhibiting ace |
| 06/04/2009 | US20090143310 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143307 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143306 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143305 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143304 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143303 Anti-invasive and anti-angiogenic compositions |
| 06/04/2009 | US20090143302 Pyrimidine compounds |
| 06/04/2009 | US20090143301 High calorie nutritional supplement |
| 06/04/2009 | US20090143300 Treatment of sepsis and septic shock using ghrelin and growth hormone |
| 06/04/2009 | US20090143299 Novel antimicrobial peptides and use thereof |
| 06/04/2009 | US20090143297 Modulators of antiestrogen pharmacology |
| 06/04/2009 | US20090143296 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/04/2009 | US20090143295 Peptide-based antiacne reagents |
| 06/04/2009 | US20090143294 Administering a sub-constricting amount of calyculin A and a vasoconstrictor where the sub-constricting amount is sufficient to restore blood vessel sensitivity to the vasoconstrictor and does not cause contraction of the blood vessel itself; antishock agents; a myosin light chain phosphatase inhibitor |
| 06/04/2009 | US20090143293 Peptide inhibitors of protein kinase C gamma for pain management |
| 06/04/2009 | US20090143292 Liquid Formulation of G-CSF Conjugate |
| 06/04/2009 | US20090143291 Tumor antigen based on products of the tumor suppressor gene wt1 |
| 06/04/2009 | US20090143290 Tumor-inhibiting protein and the use thereof |
| 06/04/2009 | US20090143289 Orthopoxvirus vectors, genes and products thereof |
| 06/04/2009 | US20090143288 Peptide-complement conjugates |
| 06/04/2009 | US20090143287 Tissue regeneration substrate |
| 06/04/2009 | US20090143286 Methods and Compositions for Regenerating Articular Cartilage |
| 06/04/2009 | US20090143285 Target protein and target gene for drug discovery and screening method |
| 06/04/2009 | US20090143284 administering peptide compound wherein compound is growth hormone-releasing peptide-2 (GHRP-2) or a peptide having an amino acid sequence wherein 3rd amino acid residue from an amino terminus is a modified residue wherein a side chain is acylated by fatty acid; ghrelin is especially desirable |
| 06/04/2009 | US20090143283 Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use |
| 06/04/2009 | US20090143282 Enhanced recovery following ocular surgery |
| 06/04/2009 | US20090143281 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 06/04/2009 | US20090143280 Anti-cancer combination treatment and kit-of-parts |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090143278 Process for preparing bioactive protein-enriched whey products |
| 06/04/2009 | US20090143277 Nutritional composition for controlling blood sugar level |
| 06/04/2009 | US20090143276 Trimeric IL-1Ra |
| 06/04/2009 | US20090143275 Adiponectin receptor fragments and methods of use |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |